Gut Mucosal Immunology: How the Intestine Fights Disease

Added:

The Epithelial Barrier-First Hypothesis

While classical mucosal immunology often attributes Inflammatory Bowel Disease (IBD) to primary defects in host immune regulation—such as dysfunctional regulatory T-cells (T-regs) or impaired immune tolerance—the 'Epithelial Barrier-First' (or 'Outside-In') hypothesis offers a compelling alternative etiology. This perspective argues that the initiating event in IBD is not an inherent immune system malfunction, but rather a structural defect in the intestinal epithelial barrier and mucus layer. According to this model, genetic or environmental factors first compromise epithelial tight junctions, allowing harmless luminal microbes and dietary antigens to leak into the underlying tissue. The resulting chronic inflammation is a normal, secondary physiological response to this persistent barrier breach, rather than a primary autoimmune failure. Consequently, proponents of this view argue that therapeutic research should focus on repairing physical barrier integrity and mucosal secretion rather than solely suppressing immune responses.

Basic principles of immunology, including the distinction between innate and adaptive immune responses.
Anatomy and histology of the gastrointestinal tract, specifically the epithelial barrier, tight junctions, and lamina propria.
The concept of immunological tolerance and the general function of T-regulatory (T-reg) cells in preventing autoimmunity.
An introduction to the human gut microbiome and its symbiotic relationship with the host's immune system.
Clinical pharmacology of Inflammatory Bowel Disease (IBD) treatments, such as monoclonal antibodies (anti-TNF therapies) and immunosuppressants.
The gut-brain-microbiota axis and how mucosal inflammation influences systemic immunity and neurological health.
The role of short-chain fatty acids (SCFAs) and other dietary metabolites in modulating mucosal immunity and regulatory T-cell differentiation.
Advanced research in mucosal vaccines and targeted cell-based immunotherapies for chronic inflammatory disorders.
1.2M views21.2Klikes6:52@NatureVideoChannelOriginal Release: 2013-02-05

The gut mucosa hosts the body's largest immune cell population, where Peyer's patches sample antigens through specialized M cells and dendritic cells to promote tolerance to harmless microbes while mounting protective responses against pathogens; regulatory T cells secrete IL-10 to maintain immune homeostasis, and when this balance breaks down due to barrier disruption or genetic factors, it leads to inflammatory bowel disease characterized by excessive inflammation, neutrophil recruitment, and tissue damage.